EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions

Judit Morla-Folch iD, Anna Ranzenigo iD, Zahi Adel Fayad iD, Abraham Jozef Petrus Teunissen iD

Small · 2024

DOI: 10.1002/smll.202307502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2024. Verfasst von Judit Morla-Folch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Hauptthemen laut MEDLINE: Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 319 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanomaterials have revolutionized medicine by enabling control over drugs’ pharmacokinetics, biodistribution, and biocompatibility. However, most nanotherapeutic batches are highly heterogeneous, meaning they comprise nanoparticles that vary in size, shape, charge, composition, and ligand functionalization. Similarly, individual nanotherapeutics often have heterogeneously distributed components, ligands, and charges. This review discusses nanotherapeutic heterogeneity's sources and effects on experimental readouts and therapeutic efficacy. Among other topics, it demonstrates that heterogeneity exists in nearly all nanotherapeutic types, examines how nanotherapeutic heterogeneity arises, and discusses how heterogeneity impacts nanomaterials’ in vitro and in vivo behavior. How nanotherapeutic heterogeneity skews experimental readouts and complicates their optimization and clinical translation is also shown. Lastly, strategies for limiting nanotherapeutic heterogeneity are reviewed and recommendations for developing more reproducible and effective nanotherapeutics provided.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesHumansAnimalsNanostructuresNanomedicine

Stichwörter der Autor:innen

discretedispersitynanomaterialsnanomedicinenanopharmaceuticalsingle particle

Autor:innen und Institutionen

  • Biomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
  • Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

ORCID-Profile: Judit Morla-Folch, Anna Ranzenigo, Zahi Adel Fayad, Abraham Jozef Petrus Teunissen

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Morla-Folch, J., Ranzenigo, A., Fayad, Z. A., & Teunissen, A. J. P. (2024). Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions. Small. https://doi.org/10.1002/smll.202307502

Vancouver

Morla-Folch J, Ranzenigo A, Fayad ZA, Teunissen AJP. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions. Small. 2024. doi:10.1002/smll.202307502

BibTeX
@article{MorlaFolch2024,
  author = {Morla-Folch, Judit and Ranzenigo, Anna and Fayad, Zahi Adel and Teunissen, Abraham Jozef Petrus},
  title = {Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions},
  journal = {Small},
  year = {2024},
  doi = {10.1002/smll.202307502}
}
Kostenlos starten →